Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

Simone Trolle; Charlotte Duch Lynggaard; Kristine Grubbe Gregersen; Louise Baandrup; Christian Grønhøj; Christian von Buchwald

Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

Translated title of the contribution: Perspectives on recurrent respiratory papillomatosis and human papillomavirus

Simone Trolle
, Charlotte Duch Lynggaard
, Kristine Grubbe Gregersen
, Louise Baandrup
, Christian Grønhøj
, Christian von Buchwald

Abstract

Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.

Translated title of the contribution	Perspectives on recurrent respiratory papillomatosis and human papillomavirus
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	181
Issue number	41
Pages (from-to)	V05190279
ISSN	0041-5782
Publication status	Published - 7 Oct 2019

Cite this

@article{82e342020a514e33abebcb15868d7be6,

title = "Perspektiver p{\aa} recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination",

abstract = "Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.",

author = "Simone Trolle and Lynggaard, \{Charlotte Duch\} and Gregersen, \{Kristine Grubbe\} and Louise Baandrup and Christian Gr{\o}nh{\o}j and Buchwald, \{Christian von\}",

year = "2019",

month = oct,

day = "7",

language = "Dansk",

volume = "181",

pages = "V05190279",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "41",

}

TY - JOUR

T1 - Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

AU - Trolle, Simone

AU - Lynggaard, Charlotte Duch

AU - Gregersen, Kristine Grubbe

AU - Baandrup, Louise

AU - Grønhøj, Christian

AU - Buchwald, Christian von

PY - 2019/10/7

Y1 - 2019/10/7

N2 - Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.

AB - Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.

M3 - Tidsskriftartikel

C2 - 31610833

SN - 0041-5782

VL - 181

SP - V05190279

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 41

ER -

Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

Abstract

Fingerprint

Cite this